• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Elite Pharmaceuticals Inc

+ Add to Watchlist


0.2277 USD 0.0013 0.57%

As of 20:10:00 ET on 12/26/2014.

Snapshot for Elite Pharmaceuticals Inc (ELTP)

Open: 0.2300 Day's Range: 0.2206 - 0.2350 Volume: 761,297
Previous Close: 0.2290 52wk Range: 0.1190 - 0.9700 1-Yr Rtn: +90.54%

Stock Chart for ELTP

No chart data available.
  • ELTP:US 0.2277
  • 1D
  • 1M
  • 1Y
Interactive ELTP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ELTP

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -0.1446
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 135.85
Shares Outstanding (M) 596.61
30 Day Average Volume 1,908,550
Price/Book (mrq) -
Price/Sale (ttm) 24.0051
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/13/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ELTP

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ELTP

Elite Pharmaceuticals, Inc. researches, develops, licenses, and manufactures both new and generic oral controlled-release pharmaceutical products. The Company has pain products in clinical trials and has developed products incorporating therapeutic agents such as cardiovasculars, antidiabetic, cough and cold preparations, and anti-infectives.

Nasrat HakimPresident/CEOCarter J WardCFO/Secretary/Treasurer
Ashok G NigalayeChief Scientific Officer
More Company Profile & Key Executives for ELTP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
  • ELTP News

  • Industry News

No stories found
No stories found
Sponsored Links
sec ||= nil